Moreover, KHSRP knockdown was able to further enhance the inhibitory effects of carboplatin on EMT in A549 cells, suggesting that downregulation of KHSRP could enhance carboplatin sensitivity in NSCLC through the inhibition of EMT. This evidence concerns the gene KHSRP and non-small cell lung carcinoma.